Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
Public ClinicalTrials.gov record NCT05517421. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants With Active Thyroid Eye Disease (TED)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW for 12 weeks versus placebo on proptosis responder rate at Week 24.
Study identification
- NCT ID
- NCT05517421
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2022 (Actual)
- Primary completion
- Nov 2, 2025 (Actual)
- Completion
- Nov 18, 2025 (Actual)
- Last update posted
- Dec 3, 2025
2022 – 2025
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Number - 1557 | Beverly Hills | California | 90210 | — |
| Site Number - 1539 | Carlsbad | California | 92011 | — |
| Site Number - 1502 | Los Angeles | California | 90025 | — |
| Site Number - 1505 | Los Angeles | California | 90033 | — |
| Site Number - 1532 | Los Angeles | California | 90255 | — |
| Site Number - 1537 | San Diego | California | 92108 | — |
| Site Number - 1531 | Torrance | California | 90505 | — |
| Site Number - 1501 | Aurora | Colorado | 80045 | — |
| Site Number - 1544 | Longmont | Colorado | 80503 | — |
| Site Number - 1547 | Newark | Delaware | 19713 | — |
| Site Number - 1504 | Miami | Florida | 33136 | — |
| Site Number - 1538 | Port Charlotte | Florida | 33952 | — |
| Site Number - 1542 | Tampa | Florida | 33603 | — |
| Site Number - 1536 | West Palm Beach | Florida | 33401 | — |
| Site Number - 1554 | Stockbridge | Georgia | 30281 | — |
| Site Number - 1534 | Chicago | Illinois | 60610 | — |
| Site Number - 1545 | Iowa City | Iowa | 52242 | — |
| Site Number - 1535 | Baltimore | Maryland | 21231 | — |
| Site Number - 1506 | Boston | Massachusetts | 02130 | — |
| Site Number - 1540 | Las Vegas | Nevada | 89184 | — |
| Site Number - 1530 | Chapel Hill | North Carolina | 27517 | — |
| Site Number - 1550 | Columbus | Ohio | 43215 | — |
| Site Number - 1507 | Portland | Oregon | 97232 | — |
| Site Number - 1556 | Warwick | Rhode Island | 02886 | — |
| Site Number - 1551 | Dallas | Texas | 75231 | — |
| Site Number - 1508 | Houston | Texas | 77030 | — |
| Site Number - 1558 | Mesquite | Texas | 75149 | — |
| Site Number - 1500 | Roanoke | Virginia | 24018 | — |
| Site Number - 1509 | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05517421, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2025 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05517421 live on ClinicalTrials.gov.